Trazodone - Solicitation
ID: SPE2D2-26-R-0003Type: Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/workspace/contract/opp/d42929d963ae4248a44bdb8675f2fc97/view
Timeline
    Description

    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting proposals for Trazodone tablets in various dosages and bottle counts. This procurement aims to secure a substantial quantity of pharmaceutical supplies essential for military and healthcare operations. Offerors are required to submit their proposals electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) by December 12, 2025, at 3:00 PM EST, with no alternative submission methods accepted. Interested parties can reach out to Nancy Fernandez at nancy.fernandez@dla.mil or Jason Wray at jason.wray@dla.mil for further inquiries regarding the solicitation.

    Files
    Title
    Posted
    SF30_SPE2D226R00030001.pdf
    This government file outlines specific requirements for proposals, emphasizing the importance of adherence to all terms and conditions. It details the process for receiving and evaluating offers, specifying that all submissions must acknowledge receipt and conform to outlined formats and deadlines. The document includes instructions for signing and returning the solicitation, noting that any modifications to the original terms must be clearly indicated. It also specifies packaging and labeling requirements for submitted materials, emphasizing that units of issue and quantity per unit must align with the contract or purchase order. The file ensures that all technical and quality requirements take precedence, with a clear focus on accountability and compliance for all involved parties.
    SF30_SPE2D226R00030002.pdf
    This government file outlines the terms and conditions for submitting proposals for unspecified services, emphasizing the importance of timely submission and adherence to specified procedures. It details the process for proposal receipt, including designated methods for delivery and the requirement for official acknowledgment. The document also addresses modifications, withdrawals, and extensions, stating that all terms and conditions referenced remain unchanged unless explicitly modified. Key aspects include instructions for offerors to sign and return the document, a clear designation of the issuing office, and the methods for submitting proposals. The file also specifies the type of modification and authority for changes, ensuring all parties are aware of the legal and procedural framework governing the solicitation.
    Trazodone - Solicitation - SPE2D2-26-R-0003.pdf
    This government solicitation, SPE2D2-26-R-0003, outlines the requirements for offers of Trazodone tablets in various dosages and bottle counts. The document emphasizes electronic submission via the Defense Logistics Agency Internet Bid Board System (DIBBS) by December 12, 2025, at 3:00 PM EST, with no alternative submission methods accepted. Key provisions include the potential for a reverse auction, mandatory subcontracting plans for large businesses, and contractor performance evaluations through CPARS. The solicitation also incorporates numerous FAR and DFARS clauses by reference, covering areas such as business ethics, telecommunications equipment restrictions (e.g., Huawei, ZTE, ByteDance), trade agreements, and specific requirements for U.S.-made or designated country end products. Offerors must maintain their Commercial and Government Entity (CAGE) code throughout the contract. The estimated quantities for Trazodone are substantial across base and option years, indicating a significant procurement for pharmaceutical supplies.
    Lifecycle
    Title
    Type
    Trazodone - Solicitation
    Currently viewing
    Solicitation
    Trazodone
    Presolicitation
    Similar Opportunities
    Ondansetron Orally Disintegrating Tablets
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Ondansetron Orally Disintegrating Tablets (ODT), specifically 4 MG and 8 MG tablets in various count bottles. This procurement aims to establish a national supply source for these pharmaceutical products, which are critical for treating nausea and vomiting in patients, and will be available for purchase by the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options, and is expected to be solicited in September 2025, although the DLA reserves the right to issue it earlier or later. Interested parties should direct inquiries to Nancy Fernandez at nancy.fernandez@dla.mil or call 445-737-0713, and are encouraged to set up automated notifications for any changes to the solicitation through the DLA Bid Board System and Sam.Gov.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Rabeprazole Sodium Delayed Release Tablets
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. The tablets will be used for medical purposes and will be available in 30, 90, and 500 count bottles. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source to provide the tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties should contact Phyllis Daraio for more information. The projected solicitation date is February 2020.
    Metformin HCL
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is planning to issue a national requirements contract for Metformin HCL ER. The contract will establish a national supply source to provide Metformin HCL ER Tablets in various quantities and bottle sizes. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The solicitation will be posted on DLA Bid Board System (DIBBS) and Sam.gov. Interested parties should contact Christopher Newman for any questions/comments. The projected solicitation date is August 2021.
    TRICARE Pharmacy Program RFI
    Dept Of Defense
    The Defense Health Agency (DHA) is conducting a Request For Information (RFI) for its next-generation TRICARE Pharmacy Program (TPharm) contract, aimed at gathering industry feedback to inform the program's requirements and design. The RFI focuses on key areas such as pharmacy benefit administration, mail order pharmacy fulfillment, enhanced care programs, and operational barriers affecting vendor participation in federal pharmacy contracts. This program is crucial as it serves over 9.6 million beneficiaries and integrates various pharmacy services, including retail and mail order options. Interested parties are encouraged to submit their responses via email to dha.buckley.ad-spt-cae.mbx.tpharm6@health.mil by January 30, 2026, at 12:00 pm MST, as the DHA seeks to utilize this information for market research purposes.
    Tretinoin Cream
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Tretinoin Cream. The cream is used for various dermatological conditions and comes in different strengths (0.025%, 0.05%, and 0.1%) and tube sizes (20G and 45G). The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. It will establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The annual usage estimates will be provided in the solicitation. Interested parties should contact Ryan Ferry for more information. The projected solicitation date is February 2023.
    42--CHEMICAL PILLS,REPL
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking quotes for the procurement of chemical pills, specifically NSN 4220014709908, with a total quantity of 2,484 units required for delivery. These chemical pills are essential for fire, rescue, and safety operations, highlighting their critical role in environmental protection and emergency response scenarios. Interested vendors must submit their quotes electronically, as hard copies of the solicitation will not be available, and all submissions should be directed to the buyer listed in the solicitation document. For inquiries, potential bidders can reach out via email at DibbsBSM@dla.mil, with the solicitation accessible through the DLA's DIBBS website.
    Ondansetron 4MG and 8MG
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Ondansetron. This contract will establish a national supply source to provide Ondansetron HCL 4 and 8MG Tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The projected solicitation date is March of 2023.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense (DoD) is seeking quotations for pharmaceutical agents as part of the Pharmacy Uniform Formulary Blanket Purchase Agreement (UF BPA) and the Uniform Formulary Additional Discount Program (UF ADP) to support the Military Health System (MHS). This procurement aims to establish an effective pharmacy benefits program, ensuring the selection of clinically and cost-effective pharmaceutical agents for inclusion in the DoD Uniform Formulary, particularly focusing on oncological agents for myelofibrosis, such as Inrebic, Jakafi, Ojjaara, and Vonjo. Interested vendors must submit their quotes by January 16, 2026, with a pre-quotation teleconference scheduled for November 20, 2025, and can direct inquiries to Tracy Banks or Stephanie Erpelding via their provided emails.
    65--TYPHOID VI POLYSACC
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking quotes for the procurement of Typhoid VI Polysaccharide, specifically under National Stock Number (NSN) 6505-01-385-6328. The procurement includes two lines: 5 units to be delivered to USS Emory S. Land AS 39 and 100 units to USS McCampbell DDG 85, both required within 20 days after order (ADO). This medical supply is crucial for immunization against typhoid fever, underscoring its importance in maintaining troop health and readiness. Interested vendors must submit their quotes electronically, and any inquiries should be directed to the buyer via email at DibbsBSM@dla.mil, with the solicitation available on the DLA's website.